Top

International Urology and Nephrology

Published in:

01-08-2012 | Nephrology – Original Paper

Quality of life and protein-energy wasting in kidney transplant recipients

Authors: Akos Ujszaszi, Maria E. Czira, Katalin Fornadi, Marta Novak, Istvan Mucsi, Miklos Z. Molnar

Published in: International Urology and Nephrology | Issue 4/2012

Abstract

Purpose

Chronic kidney disease has profound effects on the health-related quality of life (HRQoL) of patients, with serious physiological, psychological and socio-economic implications. The co-occurrence of protein-energy wasting and inflammation in end-stage renal disease patients is associated with worse HRQoL and increased mortality. We designed this study to examine the relationship between nutritional and inflammatory status and HRQoL in kidney transplant recipients.

Methods

Data from 100 randomly selected kidney transplant patients were analyzed in a cross-sectional survey. Socio-demographic parameters, laboratory results, transplantation-related data, comorbidities, medication and malnutrition-inflammation score (MIS) (Kalantar Score) were tabulated at baseline. Patients completed the Kidney Disease Quality of Life-SF (KDQoL-SF™) self-administered questionnaire.

Results

Mean age was 51 ± 13 years, median (interquartile range, IQR) time since transplantation 66 (83) months, 57% were men, and 19% had diabetes. The median (IQR) MIS was 3 (3). The MIS significantly and negatively correlated with almost all HRQoL domains analyzed, and this association remained significant in multivariate linear regression analysis for the log-transformed scores on energy/fatigue (β = −0.059 P < 0.001), bodily pain (β = −0.056 P = 0.004), physical functioning (β = −0.029, P = 0.022) and symptoms/problems (β = −0.023 P = 0.005) domains after statistical correction for age, gender, eGFR, dialysis vintage, Charlson Comorbidity Index and occupational status. Additionally, cubic spline analyses revealed linearly increasing, “dose–response” relationship between almost all domains of KDQoL-SF™ and the MIS.

Conclusions

Malnutrition-inflammation score is independently associated with different dimensions of HRQoL in kidney transplant recipients.

Available only for authorised users

Kaizu Y, Ohkawa S, Odamaki M et al (2003) Association between inflammatory mediators and muscle mass in long-term hemodialysis patients. Am J Kidney Dis 42:295–302PubMedCrossRef

Kalantar-Zadeh K, Ikizler TA, Block G et al (2003) Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 42:864–881PubMedCrossRef

Kalantar-Zadeh K, Kopple JD, Block G et al (2001) A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 38:1251–1263PubMedCrossRef

Maruyama Y, Nordfors L, Stenvinkel P et al (2005) Interleukin-1 gene cluster polymorphisms are associated with nutritional status and inflammation in patients with end-stage renal disease. Blood Purif 23:384–393PubMedCrossRef

Balakrishnan VS, Guo D, Rao M et al (2004) Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin. Kidney Int 65:1449–1460PubMedCrossRef

Raj DS, Dominic EA, Pai A et al (2005) Skeletal muscle, cytokines, and oxidative stress in end-stage renal disease. Kidney Int 68:2338–2344PubMedCrossRef

Caglar K, Peng Y, Pupim LB et al (2002) Inflammatory signals associated with hemodialysis. Kidney Int 62:1408–1416PubMedCrossRef

Fujino Y, Ishimura E, Okuno S et al (2005) C-reactive protein is a significant predictor of decrease in fat mass in hemodialysis patients. Biomed Pharmacother 59:264–268PubMedCrossRef

Carriere I, Dupuy AM, Lacroux A et al (2008) Biomarkers of inflammation and malnutrition associated with early death in healthy elderly people. J Am Geriatr Soc 56:840–846PubMedCrossRef

10.

Karadag F, Kirdar S, Karul AB et al (2008) The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Eur J Intern Med 19:104–108PubMedCrossRef

11.

Nakamura K, Moriyama Y, Kariyazono H et al (1999) Influence of preoperative nutritional state on inflammatory response after surgery. Nutrition 15:834–841PubMedCrossRef

12.

Stenvinkel P, Heimburger O, Paultre F et al (1999) Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55:1899–1911PubMedCrossRef

13.

Prakash J, Raja R, Mishra RN et al (2007) High prevalence of malnutrition and inflammation in undialyzed patients with chronic renal failure in developing countries: a single center experience from eastern India. Ren Fail 29:811–816PubMedCrossRef

14.

Kalantar-Zadeh K, Kopple JD (2001) Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis 38:1343–1350PubMedCrossRef

15.

Stenvinkel P, Heimburger O, Lindholm B et al (2000) Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 15:953–960PubMedCrossRef

16.

Wang AY, Woo J, Lam CW et al (2005) Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 20:1676–1685PubMedCrossRef

17.

Morena M, Delbosc S, Dupuy AM et al (2005) Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation. Hemodial Int 9:37–46PubMedCrossRef

18.

Kalantar-Zadeh K, McAllister CJ, Lehn RS et al (2003) Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis 42:761–773PubMedCrossRef

19.

Locatelli F, Andrulli S, Memoli B et al (2006) Nutritional-inflammation status and resistance to erythropoietin therapy in haemodialysis patients. Nephrol Dial Transplant 21:991–998PubMedCrossRef

20.

Lopes AA, Elder SJ, Ginsberg N et al (2007) Lack of appetite in haemodialysis patients associations with patient characteristics, indicators of nutritional status and outcomes in the international DOPPS. Nephrol Dial Transplant 22:3538–3546PubMedCrossRef

21.

Czira ME, Lindner AV, Szeifert L et al (2011) Association between the malnutrition-inflammation score and depressive symptoms in kidney transplanted patients. Gen Hosp Psychiatry 33:157–165PubMedCrossRef

22.

Molnar MZ, Keszei A, Czira ME et al (2010) Evaluation of the malnutrition-inflammation score in kidney transplant recipients. Am J Kidney Dis 56:102–111PubMedCrossRef

23.

Molnar MZ, Czira ME, Rudas A et al (2011) Association between the malnutrition-inflammation score and post-transplant anaemia. Nephrol Dial Transplant 26:2000–2006PubMedCrossRef

24.

Molnar MZ, Czira ME, Rudas A et al (2011) Association of the malnutrition-inflammation score with clinical outcomes in kidney transplant recipients. Am J Kidney Dis 58:101–108PubMedCrossRef

25.

Talas MS, Bayraktar N (2004) Kidney transplantation: determination of the problems encountered by Turkish patients and their knowledge and practices on healthy living. J Clin Nurs 13:580–588PubMedCrossRef

26.

Lew SQ, Piraino B (2005) Quality of life and psychological issues in peritoneal dialysis patients. Semin Dialysis 18:119–123CrossRef

27.

Sayin A, Mutluay R, Sindel S (2007) Quality of life in hemodialysis, peritoneal dialysis, and transplantation patients. Transplant Proc 39:3047–3053PubMedCrossRef

28.

Mingardi G, Cornalba L, Cortinovis E et al (1999) Health-related quality of life in dialysis patients. A report from an Italian study using the SF-36 health survey. DIA-QOL Group. Nephrol Dial Transplant 14:1503–1510PubMedCrossRef

29.

Kimmel PL, Peterson RA, Weihs KL et al (1995) Aspects of quality of life in hemodialysis patients. J Am Soc Nephrol 6:1418–1426PubMed

30.

Kimmel PL, Peterson RA, Weihs KL et al (1996) Psychologic functioning, quality of life, and behavioral compliance in patients beginning hemodialysis. J Am Soc Nephrol 7:2152–2159PubMed

31.

Mazairac AH, de Wit GA, Penne LE et al (2011) Protein-energy nutritional status and kidney disease-specific quality of life in hemodialysis patients. J Ren Nutr 21:376–386PubMedCrossRef

32.

Jassal SV, Schaubel DE, Fenton SS (2005) Baseline comorbidity in kidney transplant recipients: a comparison of comorbidity indices. Am J Kidney Dis 46:136–142PubMedCrossRef

33.

Levey A, Greene T, Kusek J et al (2000) A simplified equation to predict glomerular filtration rate from serum creatinine {Abstract}. J Am Soc Nephrol 11:155A

34.

Kalantar-Zadeh K, Kleiner M, Dunne E et al (1998) Total iron-binding capacity-estimated transferrin correlates with the nutritional subjective global assessment in hemodialysis patients. Am J Kidney Dis 31:263–272PubMedCrossRef

35.

Enia G, Sicuso C, Alati G et al (1993) Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant 8:1094–1098PubMed

36.

Hays RD, Kallich JD, Mapes DL et al (1994) Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res 3:329–338PubMedCrossRef

37.

Hays R, Kallich J, Mapes D et al. (1997) Kidney disease quality of life short form (KDQOL-SFTM), Version 1.3: a manual for use and scoring. Santa Monica, CA

38.

Korevaar JC, Merkus MP, Jansen MA et al (2002) Validation of the KDQOL-SF: a dialysis-targeted health measure. Qual Life Res 11:437–447PubMedCrossRef

39.

Duarte PS, Miyazaki MC, Ciconelli RM et al (2003) Translation and cultural adaptation of the quality of life assessment instrument for chronic renal patients (KDQOL-SF). Rev Assoc Med Bras 49:375–381PubMedCrossRef

40.

Green J, Fukuhara S, Shinzato T et al (2001) Translation, cultural adaptation, and initial reliability and multitrait testing of the Kidney Disease Quality of Life instrument for use in Japan. Qual Life Res 10:93–100PubMedCrossRef

41.

Barotfi S, Molnar MZ, Almasi C et al (2006) Validation of the Kidney Disease Quality of Life-Short Form questionnaire in kidney transplant patients. J Psychosom Res 60:495–504PubMedCrossRef

42.

Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401CrossRef

43.

Novak M, Molnar MZ, Szeifert L et al (2010) Depressive symptoms and mortality in patients after kidney transplantation: a prospective prevalent cohort study. Psychosom Med 72:527–534PubMedCrossRef

44.

Szeifert L, Molnar MZ, Ambrus C et al (2010) Symptoms of depression in kidney transplant recipients: a cross-sectional study. Am J Kidney Dis 55:132–140PubMedCrossRef

45.

Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef

46.

Rambod M, Bross R, Zitterkoph J et al (2009) Association of malnutrition-inflammation score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. Am J Kidney Dis 53:298–309PubMedCrossRef

47.

Bilgic A, Akgul A, Sezer S et al (2007) Nutritional status and depression, sleep disorder, and quality of life in hemodialysis patients. J Ren Nutr 17:381–388PubMedCrossRef

48.

Kalantar-Zadeh K, Kopple JD, Block G et al (2001) Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol 12:2797–2806PubMed

49.

Kalantar-Zadeh K, Kuwae N, Wu DY et al (2006) Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr 83:202–210PubMed

50.

Feroze U, Noori N, Kovesdy CP et al (2011) Quality-of-life and mortality in hemodialysis patients: roles of race and nutritional status. Clin J Am Soc Nephrol 6:1100–1111PubMedCrossRef

51.

Ibrahim S, El Salamony O (2008) Depression, quality of life and malnutrition-inflammation scores in Hemodialysis Patients. Am J Nephrol 28:784–791PubMedCrossRef

52.

Micozkadioglu H, Micozkadioglu I, Zumrutdal A et al (2006) Relationship between depressive affect and malnutrition-inflammation complex syndrome in haemodialysis patients. Nephrology (Carlton, Vic) 11:502–505CrossRef

53.

Valderrabano F, Jofre R, Lopez-Gomez JM (2001) Quality of life in end-stage renal disease patients. Am J Kidney Dis 38:443–464PubMedCrossRef

54.

Shidler NR, Peterson RA, Kimmel PL (1998) Quality of life and psychosocial relationships in patients with chronic renal insufficiency. Am J Kidney Dis 32:557–566PubMedCrossRef

55.

Mucsi I, Molnar MZ, Ambrus C et al (2005) Restless legs syndrome, insomnia and quality of life in patients on maintenance dialysis. Nephrol Dial Transplant 20:571–577PubMedCrossRef

56.

Mucsi I, Molnar MZ, Rethelyi J et al (2004) Sleep disorders and illness intrusiveness in patients on chronic dialysis. Nephrol Dial Transplant 19:1815–1822PubMedCrossRef

57.

Molnar MZ, Novak M, Szeifert L et al (2007) Restless legs syndrome, insomnia, and quality of life after renal transplantation. J Psychosom Res 63:591–597PubMedCrossRef

58.

Koivunen K, Lukkarinen H (2006) Lower limb atherosclerotic disease causes various deteriorations of patients’ health-related quality of life. J Vasc Nurs 24:102–115PubMedCrossRef

59.

Kalantar-Zadeh K, Kopple JD, Kamranpour N et al (2007) HDL-inflammatory index correlates with poor outcome in hemodialysis patients. Kidney Int 72:1149–1156PubMedCrossRef

60.

Molnar MZ, Novak M, Ambrus C et al (2005) Anemia in kidney transplanted patients. Clin Transplant 19:825–833PubMedCrossRef

61.

Rebollo P, Baltar JM, Campistol JM et al (2004) Quality of life of patients with chronic renal allograft rejection and anemia. J Nephrol 17:531–536PubMed

62.

Gerson A, Hwang W, Fiorenza J et al (2004) Anemia and health-related quality of life in adolescents with chronic kidney disease. Am J Kidney Dis 44:1017–1023PubMedCrossRef

Title: Quality of life and protein-energy wasting in kidney transplant recipients
Authors: Akos Ujszaszi
Maria E. Czira
Katalin Fornadi
Marta Novak
Istvan Mucsi
Miklos Z. Molnar
Publication date: 01-08-2012
Publisher: Springer Netherlands
Published in: International Urology and Nephrology / Issue 4/2012
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-012-0122-3

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2012

The role of free to total PSA ratio in prediction of extracapsular tumor extension and biochemical recurrence after radical prostatectomy in patients with PSA between 4 and 10 ng/ml

Is sampling transitional zone in patients who had prior negative prostate biopsy necessary?

Glomerular filtration rate is related to severity of obstructive coronary artery disease in patients undergoing coronary angiography

Metastatic pulmonary calcification in chronic renal failure

Bacterial sepsis following prostatic biopsy

Severity of nephrotic IgA nephropathy according to the Oxford classification

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials